Earnings Breakdown: Voyager Therapeutics Q4
Voyager Therapeutics, Inc. VYGR | 3.96 3.96 | -0.25% 0.00% Post |
Voyager Therapeutics (NASDAQ:VYGR) released its Q4 earnings on Monday, March 9, 2026 at 04:00 PM.
Here's what's important from the earnings announcement.
Earnings
Voyager Therapeutics beat estimated earnings by 11.54%, reporting an EPS of $-0.46 versus an estimate of $-0.52.
Revenue was up $9.06 million from the same period last year.
Earnings History Overview
The company beat on EPS by $0.05 in the previous quarter, leading to a 0.0% increase share price change the next day.
Here's a look at Voyager Therapeutics's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.52 | -0.51 | -0.44 | -0.35 |
| EPS Actual | -0.47 | -0.57 | -0.53 | -0.59 |
| Revenue Estimate | 8.12M | 10.37M | 13.55M | 16.58M |
| Revenue Actual | 13.37M | 5.20M | 6.47M | 6.28M |
To track all earnings releases for Voyager Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.